TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Sirnaomics Ltd. ( (HK:2257) ) has provided an announcement.
Sirnaomics Ltd. has announced its unaudited condensed consolidated interim results for the six months ending June 30, 2025. The interim results, which comply with the Hong Kong Stock Exchange’s listing rules, will be available on the company’s website and dispatched to shareholders in early September 2025. This announcement reflects the company’s commitment to transparency and regulatory compliance, potentially impacting its market position and stakeholder confidence.
The most recent analyst rating on (HK:2257) stock is a Hold with a HK$8.50 price target. To see the full list of analyst forecasts on Sirnaomics Ltd. stock, see the HK:2257 Stock Forecast page.
More about Sirnaomics Ltd.
Sirnaomics Ltd. is a biotechnology company incorporated in the Cayman Islands, focusing on the development of RNAi therapeutics. It operates within the pharmaceutical industry and is listed on the Hong Kong Stock Exchange.
Average Trading Volume: 782,390
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.05B
For a thorough assessment of 2257 stock, go to TipRanks’ Stock Analysis page.